Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026
Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael…
Markets could face ‘everything bubble’ as selloff rages on
Global stocks have fluctuated wildly over the past week, as concerns about AI valuations hang over equity markets.…
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of…
UK’s GSK announces $30 billion U.S. pharma investment amid Trump state visit
Rafael Henrique | Lightrocket | Getty Images Britain’s GSK on Wednesday became the latest pharmaceutical firm to commit…